Viewing Study NCT06481774



Ignite Creation Date: 2024-07-17 @ 12:06 PM
Last Modification Date: 2024-10-26 @ 3:33 PM
Study NCT ID: NCT06481774
Status: RECRUITING
Last Update Posted: 2024-07-03
First Post: 2024-06-24

Brief Title: Promoting Access Resources and Treatment Through Novel and Equitable Solutions for Cancer Care
Sponsor: Case Comprehensive Cancer Center
Organization: Case Comprehensive Cancer Center

Study Overview

Official Title: PARTNERS Promoting Access Resources and Treatment Through Novel and Equitable Solutions for Cancer Care
Status: RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PARTNERS
Brief Summary: The purpose of this research is to evaluate a novel integrated approach to providing navigation services to improve cancer outcomes and quality of life
Detailed Description: In a seminal paper published in 1995 Dr Harold Freeman proposed that Patient navigators act as patient advocates for patients with abnormal Cancer screening findingsSince that article was published there has been an extensive literature to support the value of patient navigation services to promote timely and complete receipt of cancer care services for participants newly diagnosed with cancer as well as along the continuum of cancer treatment including among underserved populations Despite this literature it was not until January 2024 that the Centers for Medicare and Medicaid Services CMS formally recognized patient navigation as a reimbursable service in clinical settings A key value that is attributed to PN services is the ability of navigational processes to improve equitable cancer caner service deliver for participants irrespective of a persons social determinants of health SDOHs composition including factors like financial stability educational attainment access to health care raceethnicity andor rurality of residence

In response to the unmet and significant need to reduce disparities in cancer care delivery in 2022 the Merck Foundation launched a national effort to select 8 grantees across the United States US to develop a national sustainable model to improve equitable cancer care services which in turn should help reduce the long-standing pervasive disparities observed in cancer outcomes for persons of minority raceethnic status andor SDOHs As part of this Alliance the Case CCC and CWRU PARTNERS study team will develop and examine elements of patient navigational processes that promote timely receipt of cancer care services more effective patient-provider-systems-level communication around cancer care while addressing the SDOH needs of participants and ensuring receipt of services after participant referrals closed loops This project proposes an intentional focus on engaging persons who represent medically disadvantaged or fragile populations defined here as Greater Cleveland area residents who are BlackAfrican American Hispanic andor reside in a zip code with high area deprivation indices

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None